NWBO - Northwest Biotherapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

543.6M

Cash

2.478M

Avg Qtr Burn

-13.7M

Short % of Float

1.29%

Insider Ownership

9.16%

Institutional Own.

0.05%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
DCVax-L (personalized immune therapy) Details Glioblastoma	NDA Acceptance for review	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.